Form 4 Tracker
Christopher A. Kroeger

Director, Chief Executive Officer · 7 filings · Latest: Jul 15, 2026

MapLight Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerJul 17, 2026
Sale
$37.9016,779$635.9K1,246,455
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerJul 16, 2026
Sale
$36.7969,082$2.5M1,263,234
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerJul 15, 2026
Sale
$36.6961,778$2.3M1,332,316
MPLT
Kroeger Christopher A.Jul 15, 2026
Proposed Sale
$37.91152,230$5.8M
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 18, 2026
Sale
$27.19118,235$3.2M1,394,094
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 11, 2026
Sale
$30.1113,980$421.0K1,512,329
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 8, 2026
Sale
$27.6934,411$952.8K1,526,309
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 7, 2026
Sale
$28.6520,100$575.8K1,560,720
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 6, 2026
Sale
$28.7623,701$681.6K1,580,820
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 5, 2026
Sale
$28.2010,472$295.3K1,604,521
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerMay 4, 2026
Sale
$27.9615,571$435.4K1,614,993
MPLT
Kroeger Christopher A.May 4, 2026
Proposed Sale
$30.70236,470$7.3M
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerApr 16, 2026
Sale
$27.3710,052$275.1K1,630,564
MPLT
Christopher A. KroegerDirector, Chief Executive OfficerApr 15, 2026
Sale
$26.939,135$246.0K1,640,616
MPLT
Kroeger Christopher A.Apr 15, 2026
Proposed Sale
$27.0220,822$562.6K